DS0406 - 2016

Modulation of brain activity by bacterial peptidoglycans – PG-Brain

Submission summary

Metazoans have developed highly conserved pathways to detect the proliferation of bacteria through the recognition of peptidoglycans (PG) shed from the bacterial cell wall. In mammals, the cytosolic receptors Nod1 and Nod2 recognize PG and activate an array of functions in the immune system. PG-mediated activation of Nod1 and Nod2 is also involved in the development of the immune system and acts in organs distant from bacterial niches, such as the bone marrow and the brain. In preliminary experiments, we found that Nod2-deficient mice develop significant affective, cognitive and behavioral defects. Furthermore, we observed expression of Nod2 by neurons and microglia in specific areas of the brain, and that PG given by oral gavage penetrates the brain. Thus, we suggest that a universal recognition system of bacterial activity, used by the innate immune system, serves also in the brain to adjust cognitive functions and behavioral responses. To further investigate this hypothesis based on concerted peripheral and central actions, we propose to perform a series of experiments to understand how PG-mediated activation of Nod2 translates into effects on brain functions and behaviors. This project may lead to novel therapeutic avenues against mental diseases based on the recognition of microbiota by the nervous system.

Project coordination

Gerard Eberl (INSTITUT PASTEUR (BP))

The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.

Partnership

INSTITUT PASTEUR (BP)
INSTITUT PASTEUR (BP)
INSTITUT PASTEUR (BP)

Help of the ANR 747,924 euros
Beginning and duration of the scientific project: December 2016 - 48 Months

Useful links

Explorez notre base de projets financés

 

 

ANR makes available its datasets on funded projects, click here to find more.

Sign up for the latest news:
Subscribe to our newsletter